Lakefront Biotherapeutics NV
LKFT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001421876
No open-market purchases or sales by Lakefront Biotherapeutics NV insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $960.3M in total; Greenlight Capital is the only superinvestor holding it.
Other share classesGLPGF
Q1 2023 vs. Q4 2022
How the institutions holding Lakefront Biotherapeutics NV changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 75 | 76 | +1 |
| Shares | 13.2M | 18.2M | +5.04M (+38.2%) |
| Value | $584.8M | $703.8M | +$119.0M (+20.3%) |
New holders (19)
Institutions that held Lakefront Biotherapeutics NV at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Primecap Management Co | 657,377 | $25.4M | 0.02% |
| Logos Global Management LP | 350,000 | $13.5M | 1.94% |
| Segall Bryant & Hamill, LLC | 299,391 | $11.6M | 0.12% |
| UBS Oconnor LLC | 41,250 | $1.59M | 0.04% |
| Ameriprise Financial Inc | 38,307 | $1.48M | 0.00% |
| Trexquant Investment LP | 31,599 | $1.22M | 0.03% |
| Squarepoint Ops LLC | 18,251 | $705.2K | 0.00% |
| Marshall Wace, LLP | 12,839 | $496.1K | 0.00% |
| Two Sigma Investments, LP | 11,900 | $459.8K | 0.00% |
| Aigen Investment Management, LP | 11,037 | $426.5K | 0.06% |
| LMR Partners LLP | 10,768 | $416.1K | 0.01% |
| XTX Topco Ltd | 8,416 | $325.2K | 0.07% |
| Simplex Trading, LLC | 7,604 | $293.0K | 0.01% |
| Moody National Bank Trust Division | 6,157 | $237.9K | 0.02% |
| Axq Capital, LP | 5,389 | $208.2K | 0.08% |
| Acadian Asset Management LLC | 3,273 | $126.0K | 0.00% |
| New York State Common Retirement Fund | 608 | $23.5K | 0.00% |
| Bogart Wealth, LLC | 49 | $1.89K | 0.00% |
| Values First Advisors, Inc. | 0 | $1 | 0.00% |
Sold out (18)
Institutions that held Lakefront Biotherapeutics NV at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Ally Bridge Group (NY) LLC | 140,054 | $6.22M |
| Price T Rowe Associates Inc | 128,160 | $5.69M |
| D. E. Shaw & Co., Inc. | 59,996 | $2.66M |
| Sessa Capital IM, L.P. | 46,583 | $2.07M |
| HighVista Strategies LLC | 20,701 | $918.7K |
| Shay Capital LLC | 20,000 | $887.6K |
| Manufacturers Life Insurance Company, The | 12,189 | $542.9K |
| TD Asset Management Inc | 8,900 | $395.0K |
| Envestnet Asset Management Inc | 7,469 | $331.5K |
| Campbell & CO Investment Adviser LLC | 6,534 | $290.0K |
| Y-Intercept (Hong Kong) Ltd | 4,690 | $208.1K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 437 | $19.4K |
| Wells Fargo & Company | 346 | $15.4K |
| Rockefeller Capital Management L.P. | 265 | $11.0K |
| WFA of San Diego, LLC | 200 | $8.88K |
| IFP Advisors, Inc | 74 | $8.00K |
| Hexagon Capital Partners LLC | 47 | $2.09K |
| Money Concepts Capital Corp | 2 | $89 |